You are here: All Products  > Innovent and Lilly Report MabThera/Rituxan Biosimilar Meets Endpoints

Innovent and Lilly Report MabThera/Rituxan Biosimilar Meets Endpoints

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products